CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis - Institut des cellules Souches pour le Traitement et l'Étude des maladies Monogéniques Accéder directement au contenu
Article Dans Une Revue Human Molecular Genetics Année : 2022

CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis

Résumé

Alternative splicing has emerged as a fundamental mechanism for the spatiotemporal control of development. A better understanding of how this mechanism is regulated has the potential not only to elucidate fundamental biological principles, but also to decipher pathological mechanisms implicated in diseases where normal splicing networks are misregulated. Here, we took advantage of human pluripotent stem cells to decipher during human myogenesis the role of muscleblind-like (MBNL) proteins, a family of tissue-specific splicing regulators whose loss of function is associated with myotonic dystrophy type 1 (DM1), an inherited neuromuscular disease. Thanks to the CRISPR/Cas9 technology, we generated human-induced pluripotent stem cells (hiPSCs) depleted in MBNL proteins and evaluated the consequences of their losses on the generation of skeletal muscle cells. Our results suggested that MBNL proteins are required for the late myogenic maturation. In addition, loss of MBNL1 and MBNL2 recapitulated the main features of DM1 observed in hiPSC-derived skeletal muscle cells. Comparative transcriptomic analyses also revealed the muscle-related processes regulated by these proteins that are commonly misregulated in DM1. Together, our study reveals the temporal requirement of MBNL proteins in human myogenesis and should facilitate the identification of new therapeutic strategies capable to cope with the loss of function of these MBNL proteins.
Fichier principal
Vignette du fichier
2022 HMG.pdf (1.97 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03830948 , version 1 (21-11-2022)

Identifiants

Citer

Antoine Mérien, Julie Tahraoui-Bories, Michel Cailleret, Jean-Baptiste Dupont, Céline Leteur, et al.. CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis. Human Molecular Genetics, 2022, 31 (1), pp.41-56. ⟨10.1093/hmg/ddab218⟩. ⟨hal-03830948⟩
59 Consultations
25 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More